David Wilkes, M.D., Executive Associate Dean for Research Affairs
David S. Wilkes, M.D., joined the Pulmonary Division at the IU School of Medicine in 1992 following his training at the University of Texas Southwestern Medical Center. After completing post-doctoral training as an Amos Medical Faculty Development Scholar supported by the Robert Wood Johnson Foundation, Dr. Wilkes secured independent funding from the National Institutes of Health and has been funded continuously from NIH since 1996. He is supported currently by two major research grants focused on the immunobiology of lung transplant rejection and lung dendritic cell biology.
A former vice chair for research of the Department of Medicine, Dr. Wilkes has served as the Calvin H. English Professor of Medicine, Microbiology and Immunology and now is August M. Watanabe Professor of Medical Research. His work, and his successful scientific collaborations with School of Medicine colleagues, led to the creation of the school’s Center for Immunobiology with Dr. Wilkes as director.
As an entrepreneur, Dr. Wilkes is the founder and scientific director of ImmuneWorks Inc., an Indianapolis life sciences startup company that recently completed a joint development agreement with Lung Rx, a wholly-owned subsidiary of United Therapeutics Corporation. The agreement demonstrates the company’s success in developing a treatment for idiopathic pulmonary fibrosis (IPF), which kills more than 40,000 people each year, and for primary graft dysfunction (PGD), which is a leading cause of morbidity and mortality following lung transplantation.
David S. Wilkes, M.D.
Executive Associate Dean for Research Affairs
August M. Watanabe Professor of Medical Research
Professor of Medicine, Microbiology and Immunology
Indiana University School of Medicine
Phone: (317) 278-7020